I am a healthcare professional in the UK
I am a patient or member of the public
The European Society for Organ Transplantation (ESOT) 2023 Highlights
2 minutes
The European Society for Organ Transplantation (ESOT) 2023 Highlights
Summary of highlights from ESOT Congress 2023; 17-20th September 2023; Athens, Greece, selected by Dr Sapna Shah and Dr Muir Morton.
Dr Sapna Shah, Consultant Nephrologist and Clinical Lead for Transplantation at King’s College Hospital, and Dr Muir Morton, Clinical Director of Urology, Renal & Transplantation at Manchester Royal Infirmary, will be discussing their selected topics from the European Society for Organ Transplantation (ESOT) Congress 2023 and how these topics may impact current practice in the UK.
Challenges in managing cytomegalovirus (CMV) infection in solid organ transplant recipients.
Topics chosen:
1. Burden of Refractory/Resistant Cytomegalovirus or Cytomegalovirus Drug Intolerance in Solid Organ Transplant Recipients: European Subgroup Analysis.
2. Real-life implementation of a strategy based on CMV-specific cell-mediated immunity to guide CMV preventive therapy in solid organ transplantation.
Brightcove Video
Advancements in transplant therapies: Gamma-Delta T-Cell Therapy for post-transplant cytomegalovirus (CMV) infection and the use of SGLT-2 inhibitors in renal transplantation.
Topics chosen:
1. Gamma-Delta T cell Therapy for Post-Transplant Cytomegalovirus Infection: Proof of Concept.
2. Gliflozin in Renal Transplantation: A Multi-Centre Observational Study (GREAT-ASTRE).
Brightcove Video
Kidney transplantation: Learn more about outcomes following arterio-venous fistula ligation and restoring the regenerative capacity of old kidneys.
Topics chosen:
1. Outcomes Following Arterio-Venous Fistula Ligation Following Kidney Transplantation.
2. Can we restore the regenerative capacity of old kidneys?
Brightcove Video
References:
- Blumberg E, et al. Burden of Refractory/Resistant Cytomegalovirus or Cytomegalovirus Drug Intolerance in Solid Organ Transplant Recipients: European Subgroup Analysis. Presented at the ESOT Congress 2023; 17-20th September 2023; Athens, Greece.
- Kervella D, et al. Real-life implementation of a strategy based on CMV-specific cell-mediated immunity to guide CMV preventative therapy in solid organ transplantation. Presented at the ESOT Congress 2023; 17-20th September 2023; Athens, Greece.
- Marsѐres G, et al. Gamma-Delta T cell Therapy for Post-Transplant Cytomegalovirus Infection: Proof of Concept. Presented at the ESOT Congress 2023; 17-20th September 2023; Athens, Greece.
- Maigret L et al. Gliflozin in renal transplantation: A multi-center observational study (GREAT-ASTRE). Presented at the ESOT Congress 2023; 17-20th September 2023; Athens, Greece.
- Zhu C & Willicombe M. Outcomes following arterio-venous fistula ligation following kidney transplantation. Presented at the ESOT Congress 2023; 17-20th September 2023; Athens, Greece.
- Ferenbach D. Can we restore the regenerative capacity of old kidneys? Presented at the ESOT Congress 2023; 17-20th September 2023; Athens, Greece.
You might be interested in
1 minute
download
This concise guide to LIVTENCITY® (maribavir) is designed for clarity and ease of use. It summarises key insights from the Phase 3 SOLSTICE trial, including efficacy outcomes, safety data, and practical dosing guidance.
article
6 minutes
A summary of the safety profile of LIVTENCITY, including adverse event data and tolerability findings from clinical studies.
article
3 minutes
CMV is one of the most common infections experienced by transplant recipients
article
4 minutes
An overview of the pivotal Phase 3 SOLSTICE trial, outlining the study design, patient population, and methodology that underpin the clinical evidence for LIVTENCITY.
